FDA Inspection
Shanghai Ambiopharm Inc.Shanghai Ambiopharm Inc. – FDA Inspection, May 22, 2026
Record Details
This FDA Inspection record concerns Shanghai Ambiopharm Inc., with an inspection on May 22, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 9689973f-c3f5-4511-a15c-7b4f5524e662
Inspection Facts
- Inspection number
- 1324072
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Shanghai Ambiopharm Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| January 29, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 30, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shanghai Ambiopharm Inc.
- FDA Inspection 959934 - 2016-01-29
- FDA Inspection 854840 - 2013-08-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.